Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Biological Psychiatry

• Publication date

  2012-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.biopsych.2012.05.009PMID 22717030
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lower ß2*-nicotinic acetylcholine receptor availability in smokers with schizophrenia.

  2012cited by this paper
• Nicotinic acetylcholine receptor expression on B-lymphoblasts of healthy versus schizophrenic subjects stratified for smoking: [3H]-nicotine binding is decreased in schizophrenia and correlates with negative symptoms

  2012cited by this paper
• Glycine Transporter Inhibitor Attenuates the Psychotomimetic Effects of Ketamine in Healthy Males: Preliminary Evidence

  2012cited by this paper
• Assessment of the effects of AZD3480 on cognitive function in patients with schizophrenia.

  2012cited by this paper
• Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.

  2012cited by this paper
• Nonparametric analysis of longitudinal data in factorial experiments

  2012cited by this paper
• α7 Nicotinic receptor modulators for cognitive deficits in schizophrenia and Alzheimer's disease

  2012cited by this paper
• Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial

  2012cited by this paper
• Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.

  2011cited by this paper
• Pharmacological Enhancement of Memory and Executive Functioning in Laboratory Animals

  2011cited by this paper
• Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia.

  2011cited by this paper
• Separate and combined effects of low dose ketamine and nicotine on behavioural and neural correlates of sustained attention.

  2011cited by this paper
• Cognitive and symptomatic predictors of functional disability in schizophrenia.

  2011cited by this paper
• Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia.

  2011cited by this paper
• A comparative study of the MATRICS and IntegNeuro cognitive assessment batteries

  2010cited by this paper
• Meta-analysis of the acute effects of nicotine and smoking on human performance

  2010cited by this paper
• Review on Vocational Predictors: A Systematic Review of Predictors of Vocational Outcomes Among Individuals with Schizophrenia: An Update Since 1998

  2010cited by this paper
• The interactive effects of ketamine and nicotine on human cerebral blood flow

  2010cited by this paper
• Differential Involvement of Glutamatergic Mechanisms in the Cognitive and Subjective Effects of Smoking

  2009cited by this paper
• Effects of nicotine on novelty detection and memory recognition performance: double-blind, placebo-controlled studies of smokers and nonsmokers

  2009cited by this paper
• Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: effects of smoking status.

  2009cited by this paper
• [Smoking and schizophrenia: epidemiological and clinical features].

  2008cited by this paper
• Effects of nicotine on quinpirole- and dizocilpine (MK-801)-induced sensorimotor gating impairments in rats

  2008cited by this paper
• High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia.

  2008cited by this paper
• Galantamine for the treatment of cognitive impairments in people with schizophrenia.

  2008cited by this paper
• Nicotine Effect on Prepulse Inhibition and Prepulse Facilitation in Schizophrenia Patients

  2008cited by this paper
• Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia.

  2008cited by this paper
• Initial phase 2 trial of a nicotinic agonist in schizophrenia.

  2008cited by this paper
• The Effects of Tobacco Smoke and Nicotine on Cognition and the Brain

  2007cited by this paper
• A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia

  2007cited by this paper
• Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

  2007cited by this paper
• The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments.

  2007cited by this paper
• Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia.

  2007cited by this paper
• Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.

  2006cited by this paper
• A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms.

  2006cited by this paper
• A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia

  2006cited by this paper
• Nicotine and smoker status moderate brain electric and mood activation induced by ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist.

  2006cited by this paper
• Human Tobacco Smokers in Early Abstinence Have Higher Levels of β2* Nicotinic Acetylcholine Receptors than Nonsmokers

  2006cited by this paper
• Galantamine may improve attention and speech in schizophrenia

  2006cited by this paper
• Standardized assessment of cognitive functioning during development and aging using an automated touchscreen battery.

  2006cited by this paper
• Nicotine and clozapine selectively reverse a PCP-induced deficit of PPI in BALB/cByJ but not NMRI mice: comparison with risperidone.

  2006cited by this paper
• Proof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia

  2006cited by this paper
• Galantamine improves cognition in schizophrenic patients stabilized on risperidone.

  2006cited by this paper
• A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors.

  2005cited by this paper
• Nicotine use in schizophrenia: the self medication hypotheses.

  2005cited by this paper
• Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.

  2005cited by this paper
• Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.

  2005cited by this paper
• Nicotine reduces antisaccade errors in task impaired schizophrenic subjects.

  2004cited by this paper
• Nicotine improves delayed recognition in schizophrenic patients

  2004cited by this paper
• Strain-Specificity in Nicotine Attenuation of Phencyclidine-Induced Disruption of Prepulse Inhibition in Mice: Relevance to Smoking in Schizophrenia Patients

  2004cited by this paper
• Nicotine effects on brain function and functional connectivity in schizophrenia.

  2004cited by this paper
• Nicotinic-glutamatergic interactions and attentional performance on an operant visual signal detection task in female rats.

  2003cited by this paper
• Nicotine and nicotinic receptor involvement in neuropsychiatric disorders.

  2003cited by this paper
• Nicotine Induces Glutamate Release from Thalamocortical Terminals in Prefrontal Cortex

  2003cited by this paper
• Cognition in Schizophrenia

  2003cited by this paper
• RELATIONSHIP BETWEEN TOBACCO SMOKING AND POSITIVE AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA

  2002cited by this paper
• Nicotine and Behavioral Markers of Risk for Schizophrenia: A Double-Blind, Placebo-Controlled, Cross-Over Study

  2002cited by this paper
• Effects of Smoking Abstinence on Visuospatial Working Memory Function in Schizophrenia

  2002cited by this paper
• Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation.

  2002cited by this paper
• Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia

  2001cited by this paper
• Cognition in schizophrenia

  2001cited by this paper
• Cognitive effects of nicotine.

  2001cited by this paper
• Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings.

  2001cited by this paper
• Cellular mechanisms of nicotine addiction.

  2001cited by this paper
• Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

  2001cited by this paper
• Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

  2000cited by this paper
• Long-term potentiation of excitatory inputs to brain reward areas by nicotine.

  2000cited by this paper
• Putative role of presynaptic α7* nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area

  2000cited by this paper
• Nicotine stimulation of extracellular glutamate levels in the nucleus accumbens: Neuropharmacological characterization

  2000cited by this paper
• Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area.

  2000cited by this paper
• Nicotinic Modulation of Glutamate and GABA Synaptic Transmission in Hippocampal Neurons

  1999cited by this paper
• Nicotinic receptors in the rat prefrontal cortex: increase in glutamate release and facilitation of mediodorsal thalamo‐cortical transmission

  1999cited by this paper
• Nicotine Withdrawal and Psychiatric Symptoms in Cigarette Smokers with Schizophrenia

  1999cited by this paper
• Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

  1998influential reference
• Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings.

  1998cited by this paper
• Effects of cigarette smoking and 12-h abstention on working memory during a serial-probe recognition task

  1998cited by this paper
• Nicotine enhances sustained attention in the rat under specific task conditions

  1998cited by this paper
• Nicotinic acetylcholine involvement in cognitive function in animals

  1998cited by this paper
• Measurement of Dissociative States with the Clinician-Administered Dissociative States Scale (CADSS)

  1998cited by this paper
• Nicotine-dizocilpine interactions and working and reference memory performance of rats in the radial-arm maze.

  1998cited by this paper
• Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders.

  1998cited by this paper
• N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens.

  1997cited by this paper
• What are the functional consequences of neurocognitive deficits in schizophrenia?

  1996cited by this paper
• Hippocampal synaptic transmission enhanced by low concentrations of nicotine

  1996cited by this paper
• Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors.

  1995cited by this paper
• Normalization of auditory physiology by cigarette smoking in schizophrenic patients.

  1993cited by this paper
• The Effect of Clozapine on Cognition and Psychiatric Symptoms in Patients with Schizophrenia

  1993cited by this paper
• Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics.

  1992cited by this paper
• The development and initial validation of a questionnaire on smoking urges.

  1991cited by this paper
• The Positive and Negative Syndrome Scale (PANSS): Rationale and Standardisation

  1989cited by this paper
• A high-performance liquid-chromatographic method for routine simultaneous determination of nicotine and cotinine in plasma.

  1988cited by this paper
• Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum

  1988cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Unveiling the therapeutic potential of ketamine in depression: A bibliometric analysis and research landscape overview

  2024cites this paper
• Mechanism of psychoactive substance-induced cognitive disorders: does tau protein play a role?

  2022cites this paper
• Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders

  2022cites this paper
• A Systematic Review of Neurocognitive Effects of Subanesthetic Doses of Intravenous Ketamine in Major Depressive Disorder, Post-Traumatic Stress Disorder, and Healthy Population

  2022cites this paper
• Decreased integration of default-mode network during a working memory task in schizophrenia with severe attention deficits

  2022cites this paper
• Ketamine in the Past, Present, and Future: Mechanisms, Metabolites, and Toxicity

  2021cites this paper
• Betaine prevents and reverses the behavioral deficits and synaptic dysfunction induced by repeated ketamine exposure in mice.

  2021cites this paper
• Relationships and interactions between ionotropic glutamate receptors and nicotinic receptors in the CNS.

  2021cites this paper
• Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia

  2020cites this paper
• Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort

  2019cites this paper
• A multicenter study of ketamine effects on functional connectivity: Large scale network relationships, hubs and symptom mechanisms

  2019influential citation
• Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.

  2018cites this paper
• On the safety of repeated ketamine infusions for the treatment of depression: Effects of sex and developmental periods

  2018cites this paper
• Protective effects of tetrahydropalmatine against ketamine-induced learning and memory injury via antioxidative, anti-inflammatory and anti-apoptotic mechanisms in mice.

  2018cites this paper
• Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial

  2018cites this paper
• Interactions between cannabinoids and tobacco : implications for understanding and treating addictive disorders

  2018cites this paper
• Attenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242

  2017cites this paper
• Using transcranial direct-current stimulation (tDCS) to understand cognitive processing

  2017cites this paper
• Acute memory and psychotomimetic effects of cannabis and tobacco both ‘joint’ and individually: a placebo-controlled trial

  2017influential citation
• MAM-E17 rat model impairments on a novel continuous performance task: effects of potential cognitive enhancing drugs

  2017cites this paper
• Role of N-Methyl-D-Aspartate Receptors in Action-Based Predictive Coding Deficits in Schizophrenia.

  2017cites this paper
• Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort.

  2017cites this paper
• Ketamine: Its Safety, Tolerability, and Impact on Neurocognition

  2016cites this paper
• N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice.

  2016cites this paper
• Therapeutic Potential of α7 Nicotinic Acetylcholine Receptors

  2015cites this paper
• Developing treatments for cognitive deficits in schizophrenia: The challenge of translation

  2015cites this paper
• Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) study: the moderating role of smoking status and antipsychotic medications.

  2015cites this paper
• Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states.

  2015cites this paper
• Neurobiological background of negative symptoms

  2015cites this paper
• Drug models of schizophrenia

  2015cites this paper
• Therapeutic Advances in Psychopharmacology

  2014cites this paper
• Use of translational pharmacodynamic biomarkers in early-phase clinical studies for schizophrenia.

  2014cites this paper
• Subanesthetic Ketamine Treatment Promotes Abnormal Interactions between Neural Subsystems and Alters the Properties of Functional Brain Networks

  2014cites this paper
• Chronic administration of ketamine mimics the perturbed sense of body ownership associated with schizophrenia

  2014cites this paper
• Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism

  2014cites this paper
• Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.

  2014cites this paper
• Effects of Nicotine on the Neurophysiological and Behavioral Effects of Ketamine in Humans

  2013cites this paper
• The alpha-7 nicotinic receptor partial agonist/5-HT3 antagonist RG3487 enhances cortical and hippocampal dopamine and acetylcholine release

  2013cites this paper
• Inhibition of GABA synthesis in the prefrontal cortex increases locomotor activity but does not affect attention in the 5-choice serial reaction time task.

  2013cites this paper